Data/hora: 10/06/2024 09:16:36

Provedor de dados: | 55
País: | Brazil
Título: | A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients
Autores: | Lanzafame,Massimiliano; Bonora,Stefano; Lattuada,Emanuela; Calcagno,Andrea; Vento,Sandro.
Data: | 2011-10-01
Ano: | 2011
Palavras-chave: | HIV infections; Pharmacokinetics antiretroviral therapy; Highly active.
Resumo: | Darunavir (DRV) is an HIV-1 protease inhibitor that is used together with a low boosting dose of ritonavir as part of an antiretroviral therapy (ART) regimen in treatment-experienced and naïve HIVpositive patients. In naïve and experienced patients with no DRV-mutations, DRV is licensed at the dose of 800 mg plus 100 mg of ritonavir once daily. We report our results in seven ART-experienced HIV-infected patients, in whom a reduced dose of darunavir/ritonavir (600/100 mg once daily) successfully controlled viral replication
Tipo: | Info:eu-repo/semantics/report
Idioma: | Inglês
Identificador: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702011000500017
Editor: | Brazilian Society of Infectious Diseases
Relação: | 10.1590/S1413-86702011000500017
Formato: | text/html
Fonte: | Brazilian Journal of Infectious Diseases  v.15 n.5 2011
Fonte: | info:eu-repo/semantics/openAccess